Photobiostimulation Devices Market Size, Share, Trends, Growth and Forecast 2025

Photobiostimulation Devices Industry Prospective:

The global photobiostimulation devices market size was evaluated at $11 billion in 2022 and is slated to hit $17 billion by the end of 2030 with a CAGR of nearly 5.3% between 2023 and 2030.

Request Free Sample

Photobiostimulation Devices Market: Overview

Photobiostimulation equipment is used in reducing pain, inflammation, and edema for treating wounds, deeper nerves, and preventing damage to the tissues. Reportedly, the LEDs are used by photobiostimulation devices for producing the required wavelength light to achieve specific results. In cell mitochondria, light acts on a protein that results in enhanced ATP and decreases oxidative stress and is the prevalent concept on which photobiostimulation devices operate.  

Key Insights

• As per the analysis shared by our research analyst, the global photobiostimulation devices market is projected to expand annually at the annual growth rate of around 5.3% over the forecast timespan (2023-2030)
• In terms of revenue, the global photobiostimulation devices market size was evaluated at nearly $11 billion in 2022 and is expected to reach $17 billion by 2030.
• The global photobiostimulation devices market is anticipated to grow rapidly over the forecast timeline owing to the growing tendency for treating patients with non-invasive procedures, the rise in the number of patients affected due to chronic pain, and the need for cost-effective treatments.
• In terms of type, the infra-red light segment is slated to register the highest CAGR over the analysis period.
• Based on applications, the pain management segment is expected to dominate the segmental growth over the assessment timeline.
• Region-wise, the Asia-Pacific photobiostimulation devices industry is projected to register the fastest CAGR during the assessment timeline.

Photobiostimulation Devices Market: Growth Factors

Massive need of treating patients with non-invasive methods will boost the expansion of the global market by 2030

Factors such as the growing tendency for treating patients with non-invasive procedures, rise in the number of patients affected due to chronic pain, and the need for cost-effective treatments will boost the global photobiostimulation devices market expansion in the coming years. An increase in the aging populace prone to chronic disorders will steer the growth of the global market. Surge in chronic ailments such as osteoporosis and arthritis will expand the scope of the growth of the business space in the years ahead. A prominent increment in cancer cases and an increase in the number of diabetics across the globe will pave the way for the expansion of the market across the globe. New product launches are likely to leverage the expansion of the market globally in the years ahead. For instance, in the second half of 2022, STRATA Skin Sciences, Inc., a healthcare technology firm, introduced TheraClear X, a non-invasive acne treatment targeting the root cause of moderate acne occurrence that include pustular, inflammatory acne vulgaris, and comedonal.

Photobiostimulation Devices Market: Restraints

Availability of counterfeit products can hinder global industry expansion over the coming years

Easy availability of duplicate products is likely to put brakes on the global photobiostimulation devices industry expansion. Apart from this, easy access to product substitutes at reasonable prices along with high product costs will further deflate the growth of the global industry.

Photobiostimulation Devices Market: Opportunities

Growing demand for cost-efficient therapies will generate new dimensions of growth for the global market

Escalating need for cost-effective treatments along with the demand for effective medical devices for treating chronic pain will open new facets of growth for the global photobiostimulation devices market in the foreseeable future.

Photobiostimulation Devices Market: Challenges

Easy access to new alternative chronic pain treatments can prove to be a huge challenge for the global industry expansion

Easy availability of alternate therapies for treating chronic pain and strict government laws pertaining to use of the product in the healthcare sector will put brakes on the expansion of the global photobiostimulation devices industry in the years ahead.

Photobiostimulation Devices Market: Segmentation

The global photobiostimulation devices market is sectored into type, applications, end-user, and region.                

In type terms, the global photobiostimulation devices market is segregated into infra-red light, red light, and others segments. Furthermore, the infra-red light segment, which amassed nearly one-fourth of the global market revenue in 2022, is set to record the highest CAGR in the ensuing years. The expansion of the segment in the forecasting timeframe can be due to rising vascularization, collagen synthesis, deep thermal surge, surge in oxygenation, and enhancement in skin elasticity.

Based on the applications, the global photobiostimulation devices industry is sectored into pain management, cosmetic applications, wound care, and other applications segments. Moreover, the pain management segment, which garnered a huge chunk of the global industry share in 2022, is expected to lead the global industry over the analysis timespan. The segmental expansion over the predicted timeline can be subject to a rise in the cases of osteoporosis and arthritis in the aging population globally.

Based on the end-user, the photobiostimulation devices market across the globe is divided into specialty clinics, research institutions, home care, and others.

Photobiostimulation Devices Market: Report Scope

Photobiostimulation Devices Market: Regional Insights

North America is prognosis to maintain leadership position in the global photobiostimulation devices market in the forecasting years

North America, which contributed about 36% of the global photobiostimulation devices market revenue in 2022, will be a dominating region over the projected timespan. Furthermore, the regional market growth can be subject to an increase in the occurrence of chronic diseases and the use of non-invasive therapies for treating pain in the aging population in countries such as Canada and the U.S. Moreover, countries such as the U.S. and Canada are likely to be the key regional revenue pockets in the coming years.

Asia-Pacific photobiostimulation devices industry is set to register the fastest CAGR in the forthcoming years owing to the presence of major device manufacturers in China, Taiwan, South Korea, Japan, India, and the Philippines. Furthermore, a rise in the product demand in the healthcare sector will further steer the regional industry trends.

Photobiostimulation Devices Market: Competitive Space

The global photobiostimulation devices market profiles key players such as:

• Omega Laser Systems
• Ingeneus Pty Ltd.
• Bioflex Laser Therapy
• Thermadome Inc.
• Hairmax
• iRestore Laser
• THOR Photomedicine

The global photobiostimulation devices market is segmented as follows:

By Application

• Pain Management
• Wound Care
• Cosmetic Applications
• Other Applications

By Type

• Infra-Red Light
• Red Light
• Others

By End-User

• Specialty Clinics
• Research Institutions
• Home Care
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa